期刊
JOURNAL OF CLINICAL PATHOLOGY
卷 56, 期 1, 页码 69-73出版社
BRITISH MED JOURNAL PUBL GROUP
DOI: 10.1136/jcp.56.1.69
关键词
-
类别
资金
- NCI NIH HHS [1-U01-CA74778., U01 CA097735] Funding Source: Medline
- NATIONAL CANCER INSTITUTE [U01CA074778, U01CA097735] Funding Source: NIH RePORTER
Aim: To determine the frequency of tumour budding and somatic APC mutation in a series of colorectal cancers stratified according to DNA microsatellite instability (MSI) status. Material/Methods: Ninety five colorectal cancers were genotyped for APC mutation in the mutation cluster region (exon 15) and scored for the presence of turnout budding at the invasive margin in haematoxylin and eosin stained sections. A subset was immunostained for beta catenin and p16. Results: The frequency of both somatic APC mutation and tumour budding increased pari passu in cancers stratified as sporadic MSI high (MSI-H), hereditary non-polyposis colorectal cancer (HNPCC), MSI low (MSI-L), and microsatellite stable (MSS). Both budding and APC mutation were significantly less frequent in sporadic MSI-H cancers than in MSI-L or MSS cancers. Tumour buds were characterised by increased immunostaining for both beta catenin and p16. Conclusion: Tumour budding is associated with an adverse prognosis. The lack of budding in MSI-H colorectal cancer may account for the improved prognosis of this subset and may be explained by an. intact WNT signalling pathway and/or inactivated p16(INK4A).
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据